Stock CEPHALON, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Cephalon, Inc.

Equities

US1567081096

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Cephalon, Inc.
2015 AstraZeneca : Teva reach deal with states in Medicaid pricing case RE
2014 Actavis : Exclusive - Valeant to drop deal-making in near term to cut debt, boost stock RE

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
CEPHALON : Teva Completes Acquisition of Cephalon
BU
CEPHALON : Announces Enrollment In the Risk Evaluation and Mitigation Strategy Program for FENTORA and ACTIQ
PU
CEPHALON : Teva and Cephalon Receive European Commission Approval For Acquisition
BU
CEPHALON : Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015
PR
CEPHALON : Reported Financial Results for the Second Quarter of 2011
PR
CEPHALON : Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ
PR
CEPHALON : Shareholders Approve Acquisition by Teva
PU
CEPHALON : to Release Second Quarter 2011 Earnings Results After the Market Close on August 2, 2011
PR
CEPHALON : Granted Temporary Restraining Order in AMRIX® Patent Litigation
PU
CEPHALON : Granted Temporary Restraining Order in AMRIX® Patent Litigation
PR
CEPHALON : Recognizes National Night Shift Worker's Day, Honors America's Shift Workers
PR
CEPHALON : Brower Piven Announces an Investigation of the Acquisition of Cephalon, Inc. by Teva Pharmaceutical Industries Ltd.
BU
CEPHALON : Reported Strong Financial Results for the First Quarter of 2011
PR
CEPHALON : Briscoe Law Firm Investigates Cephalon, Inc. for Shareholders Concerning Acquisition by Teva Pharmaceutical Industries Ltd.
BU
CEPHALON : Goldfarb Branham Law Firm LLP Investigating Shareholder Claims in Cephalon, Inc. Buyout
BU
CEPHALON : to Release First Quarter 2011 Earnings Results After the Market Close on May 3, 2011
PR
CEPHALON : Teva to Acquire Cephalon in $6.8 Billion Transaction
BU
CEPHALON : Valeant Pharmaceuticals Responds to Cephalon Board's Letter
PR
CEPHALON : Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders
PR
CEPHALON : Valeant Pharmaceuticals Announces Letter to Cephalon Stockholders
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Cephalon, Inc.
  5. Press Releases